EGFR-A763_Y764insFQEA Is a Unique Exon 20 Insertion Mutation That Displays Sensitivity to Approved and In-Development Lung Cancer EGFR Tyrosine Kinase Inhibitors
Vasconcelos, Pedro E.N.S., Gergis, Carol, Viray, Hollis, Varkaris, Andreas, Fujii, Masanori, Rangachari, Deepa, VanderLaan, Paul A., Kobayashi, Ikei S., Kobayashi, Susumu S., Costa, Daniel B.
Published in JTO clinical and research reports (01.09.2020)
Published in JTO clinical and research reports (01.09.2020)
Get full text
Journal Article
EGFR testing in advanced non-small-cell lung cancer, a mini-review
Sheikine, Yuri, MD, PhD, Rangachari, Deepa, MD, McDonald, Danielle C., NP, Huberman, Mark S., MD, Folch, Erik S., MD, MSc, VanderLaan, Paul A., MD, PhD, Costa, Daniel B., MD, PhD
Published in Clinical lung cancer (01.11.2016)
Published in Clinical lung cancer (01.11.2016)
Get full text
Journal Article
Molecular Testing Turnaround Time for Non-Small Cell Lung Cancer in Routine Clinical Practice Confirms Feasibility of CAP/IASLC/AMP Guideline Recommendations: a single center analysis
DiStasio, Marcello, MD, PhD, Chen, Yigu, MPH, Rangachari, Deepa, MD, Costa, Daniel B., MD, PhD, Heher, Yael K., MD, MPH, VanderLaan, Paul A., MD, PhD
Published in Clinical lung cancer (01.09.2017)
Published in Clinical lung cancer (01.09.2017)
Get full text
Journal Article
The Impact of On-Target Resistance Mediated by EGFR-T790M or EGFR-C797S on EGFR Exon 20 Insertion Mutation Active Tyrosine Kinase Inhibitors
Kobayashi, Ikei S., Shaffer, William, Viray, Hollis, Rangachari, Deepa, VanderLaan, Paul A., Kobayashi, Susumu S., Costa, Daniel B.
Published in JTO clinical and research reports (01.01.2024)
Published in JTO clinical and research reports (01.01.2024)
Get full text
Journal Article
High-Dose Osimertinib for CNS Progression in EGFR+ NSCLC: A Multi-Institutional Experience
Piper-Vallillo, A.J., Rotow, Julia K., Aredo, Jacqueline V., Shaverdashvili, Khvaramze, Luo, Jia, Carlisle, Jennifer W., Husain, Hatim, Muzikansky, Alona, Heist, Rebecca S., Rangachari, Deepa, Ramalingam, Suresh S., Wakelee, Heather A., Yu, Helena A., Sequist, Lecia V., Bauml, Joshua M., Neal, Joel W., Piotrowska, Zofia
Published in JTO clinical and research reports (01.06.2022)
Published in JTO clinical and research reports (01.06.2022)
Get full text
Journal Article
Acquired Resistance to Osimertinib Plus Savolitinib Is Mediated by MET-D1228 and MET-Y1230 Mutations in EGFR-Mutated MET-Amplified Lung Cancer
Piper-Vallillo, Andrew J., Halbert, Brian T., Rangachari, Deepa, Kobayashi, Susumu S., Costa, Daniel B.
Published in JTO clinical and research reports (01.11.2020)
Published in JTO clinical and research reports (01.11.2020)
Get full text
Journal Article
ALK Deletion Exons 2 to 19: Case Report of a Rare ALK Inhibitor–Responsive Lung Cancer Driver Oncogene
Schoepflin, Zachary R., Academia, Emmeline, Osataphan, Soravis A., Rangachari, Deepa, Sharifi, Sheida, VanderLaan, Paul A., Costa, Daniel B.
Published in JTO clinical and research reports (01.04.2023)
Published in JTO clinical and research reports (01.04.2023)
Get full text
Journal Article
Association Between Immune-Related Adverse Events and Clinical Outcomes to Programmed Cell Death Protein 1/Programmed Death-Ligand 1 Blockade in SCLC
Ricciuti, Biagio, Naqash, Abdul Rafeh, Naidoo, Jarushka, Sehgal, Kartik, Miller, Adam, Kehl, Kenneth, Venkatraman, Deepti, Sands, Jacob, Lamberti, Giuseppe, Recondo, Gonzalo, Zhang, Jiajia, Macherla, Shravanti, Baig, Sameer, Walker, Paul, Rangachari, Deepa, Gainor, Justin F., Costa, Daniel B., Rizvi, Naiyer, Sholl, Lynette M., Nishino, Mizuki, Henick, Brian, Farago, Anna F., Awad, Mark M.
Published in JTO clinical and research reports (01.11.2020)
Published in JTO clinical and research reports (01.11.2020)
Get full text
Journal Article
Quiz Page January 2014
Storm, Andrew, MD, Bhasin, Bhavna, MD, Rangachari, Deepa, MD, Sperati, C. John, MD, MHS
Published in American journal of kidney diseases (01.01.2014)
Published in American journal of kidney diseases (01.01.2014)
Get full text
Journal Article